Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 May;15(2):e171-6.
Epub 2015 May 28.

Ebolavirus and Haemorrhagic Syndrome

Gerald A Matua  1 , Dirk M Van der Wal  2 , Rozzano C Locsin  3
Affiliations
Review

Ebolavirus and Haemorrhagic Syndrome

Gerald A Matua et al. Sultan Qaboos Univ Med J. 2015 May.

Abstract

The Ebola virus is a highly virulent, single-stranded ribonucleic acid virus which affects both humans and apes and has fast become one of the world's most feared pathogens. The virus induces acute fever and death, with haemorrhagic syndrome occurring in up to 90% of patients. The known species within the genus Ebolavirus are Bundibugyo, Sudan, Zaïre, Reston and Taï Forest. Although endemic in Africa, Ebola has caused worldwide anxiety due to media hype and concerns about its international spread, including through bioterrorism. The high fatality rate is attributed to unavailability of a standard treatment regimen or vaccine. The disease is frightening since it is characterised by rapid immune suppression and systemic inflammatory response, causing multi-organ and system failure, shock and often death. Currently, disease management is largely supportive, with containment efforts geared towards mitigating the spread of the virus. This review describes the classification, morphology, infective process, natural ecology, transmission, epidemic patterns, diagnosis, clinical features and immunology of Ebola, including management and epidemic containment strategies.

Keywords: Disease Management; Ebolavirus; Filoviridae; Hemorrhage; Hemorrhagic Fever, Ebola; Pathogenicity Factors; Virulence.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Leroy EM, Gonzalez JP, Baize S. Ebola and Marburg haemorrhagic fever viruses: Major scientific advances, but a relatively minor public health threat for Africa. Clin Microbiol Infect. 2011;17:964–76. doi: 10.1111/j.1469-0691.2011. - DOI - PubMed
    1. Raabe VN, Borchert M. Infection control during filoviral hemorrhagic fever outbreaks. J Glob Infect Dis. 2012;4:69–74. doi: 10.4103/0974-777X.93765. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention Ebola (Ebola Virus Disease) From: www.cdc.gov/vhf/ebola/pdf/ebola-factsheet.pdf Accessed: Aug 2014. - PMC - PubMed
    1. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011;377:849–62. doi: 10.1016/S0140-6736(10)60667-8. - DOI - PMC - PubMed
    1. World Health Organization Ebola Virus Disease: Fact sheet no. 103, 2014. From: www.who.int/mediacentre/factsheets/fs103/en/ Accessed: Aug 2014.

LinkOut - more resources